Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 05, 2022

SELL
$155.97 - $200.09 $232,395 - $298,134
-1,490 Closed
0 $0
Q4 2021

Feb 08, 2022

BUY
$193.69 - $247.03 $69,728 - $88,930
360 Added 31.86%
1,490 $364,000
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $31,232 - $34,598
-165 Reduced 12.74%
1,130 $219,000
Q2 2021

Aug 12, 2021

SELL
$155.9 - $187.99 $48,329 - $58,276
-310 Reduced 19.31%
1,295 $241,000
Q4 2020

Feb 11, 2021

BUY
$157.07 - $174.35 $43,979 - $48,818
280 Added 21.13%
1,605 $266,000
Q3 2020

Nov 12, 2020

BUY
$137.1 - $165.37 $181,657 - $219,115
1,325 New
1,325 $219,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Pekin Hardy Strauss, Inc. Portfolio

Follow Pekin Hardy Strauss, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pekin Hardy Strauss, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pekin Hardy Strauss, Inc. with notifications on news.